These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30845102)

  • 41. The effects of the spleen tyrosine kinase inhibitor fostamatinib on ambulatory blood pressure in patients with active rheumatoid arthritis: results of the OSKIRA-ABPM (ambulatory blood pressure monitoring) randomized trial.
    Kitas GD; Abreu G; Jedrychowicz-Rosiak K; Miller JL; Nakov R; Panfilov S; Vencovsky J; Wang M; Weinblatt ME; White WB
    J Am Soc Hypertens; 2014 Nov; 8(11):780-90. PubMed ID: 25455003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.
    Gonzalez-Lopez TJ; Bermejo N; Cardesa-Cabrera R; Martínez V; Aguilar-Monserrate G; Pérez Segura G; García AD; Luis-Navarro J; Lakhwani S; Acedo N; Lozano ML; Bernat S; Torres-Tienza A; Ruano A; Jarque I; Galán Alvarez P; Benet Campos C; Marcellini-Antonio S; Jimenez-Bárcenas R; Martínez-Carballeira D; de Miguel Llorente D; Perona Blázquez Á; González-Gascón-Y-Marín I; Lopez-Ansoar E; Alonso Alonso JM; Bengochea-Casado ML; Díaz Gálvez FJ; Moretó A; Moreno G; Hernández-Martin R; de Cabo E; Davila-Valls J; Cuesta A; Pastoriza Cruz C; Hermida G; García C; Pozas-Mañas MA; Aguilar-Franco C; Fernandez-Jimenez D; Navas-Elorza B; López-Santamaría Castro C; Lorenzo Vizcaya A; Ortín X; Pintos MG; Piernas S; Díaz-Santa J; Soto-Ortega I; Provan D; García-Donas Gabaldón G
    Blood; 2024 Jun; ():. PubMed ID: 38843478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis.
    Zhang J; Liang Y; Ai Y; Li X; Xie J; Li Y; Zheng W; He R
    Sci Rep; 2018 Jan; 8(1):576. PubMed ID: 29330464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
    Chouhan JD; Herrington JD
    Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Simple, safe and effective. New protease inhibitor means progress].
    MMW Fortschr Med; 2002 Dec; 144(49):52-3. PubMed ID: 12577744
    [No Abstract]   [Full Text] [Related]  

  • 46. The development of romiplostim for patients with immune thrombocytopenia.
    Molineux G
    Ann N Y Acad Sci; 2011 Mar; 1222():55-63. PubMed ID: 21434943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eltrombopag: a novel oral thrombopoietin receptor agonist.
    Corman SL; Mohammad RA
    Ann Pharmacother; 2010 Jun; 44(6):1072-9. PubMed ID: 20460556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales.
    Allen R; Bryden P; Grotzinger KM; Stapelkamp C; Woods B
    Value Health; 2016; 19(5):614-22. PubMed ID: 27565278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.
    Hilgendorf I; Eisele S; Remer I; Schmitz J; Zeschky K; Colberg C; Stachon P; Wolf D; Willecke F; Buchner M; Zirlik K; Ortiz-Rodriguez A; Lozhkin A; Hoppe N; von zur Muhlen C; zur Hausen A; Bode C; Zirlik A
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):1991-9. PubMed ID: 21700926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.
    Kuwana M; Ito T; Kowata S; Hatta Y; Fujimaki K; Naito K; Kurahashi S; Kagoo T; Tanimoto K; Saotome S; Tomiyama Y
    Am J Hematol; 2024 Feb; 99(2):E55-E59. PubMed ID: 38165064
    [No Abstract]   [Full Text] [Related]  

  • 52. Romiplostim.
    Kuter DJ
    Cancer Treat Res; 2011; 157():267-88. PubMed ID: 21052962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful use of eltrombopag without splenectomy in refractory HIV-related immune reconstitution thrombocytopenia.
    Quach H; Lee LY; Smith B; Korman T; Woolley IJ
    AIDS; 2012 Sep; 26(15):1977-9. PubMed ID: 22992580
    [No Abstract]   [Full Text] [Related]  

  • 54. The Syk kinase as a therapeutic target in leukemia and lymphoma.
    Efremov DG; Laurenti L
    Expert Opin Investig Drugs; 2011 May; 20(5):623-36. PubMed ID: 21438742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic-pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA).
    Maringwa J; Kågedal M; Hamrén UW; Martin P; Cox E; Hamrén B
    J Clin Pharmacol; 2015 Mar; 55(3):328-35. PubMed ID: 25280085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
    González-Porras JR; Mingot-Castellano ME; Andrade MM; Alonso R; Caparrós I; Arratibel MC; Fernández-Fuertes F; Cortti MJ; Pascual C; Sánchez-González B; Bernat S; Fuertes-Palacio MA; Vázquez-Paganini JA; Olivera PE; Alvarez-Román MT; Jarque I; Cortés M; Martínez-Robles V; Díaz-Gálvez FJ; Calbacho M; Fernández-Miñano C; Garcia-Frade J; González-López TJ
    Br J Haematol; 2015 Apr; 169(1):111-6. PubMed ID: 25521630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baloxavir marboxil (Xofluza) for treatment of influenza.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):193-196. PubMed ID: 30653474
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of acute and chronic constipation with bisoxatin acetate and bisacodyl. Double-blind crossover study.
    Rider JA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):386-92. PubMed ID: 4996225
    [No Abstract]   [Full Text] [Related]  

  • 59. Exposure vs. response of blood pressure in patients with rheumatoid arthritis following treatment with fostamatinib.
    Boström E; Öhrn F; Hanze E; Sandström M; Martin P; Wählby-Hamrén U
    J Clin Pharmacol; 2014 Dec; 54(12):1337-46. PubMed ID: 24895144
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.